This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kishimoto, M. Articles by Yokota, J. Search for Related Content PubMed PubMed Citation Articles by Kishimoto, M. Articles by Yokota, J.

Mutations and Deletions of the CBP Gene in Human Lung Cancer

¹ Biology Division, ² Center for Medical Genomics, ³ Genetics Division, and ⁴ Molecular Oncology Division, National Cancer Center Research Institute, Tokyo, Japan; ⁵ Second Department of Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan; and ⁶ Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas

Requests for reprints: Jun Yokota, Biology Division, National Cancer Center Research Institute, 1-1 Tsukiji 5-Chome Chuo-Ku, Tokyo 104-0045, Japan; E-mail: jyokota{at}gan2.ncc.go.jp.

Purpose: Microarray-based comparative genomic hybridization analysis led us to detect a homozygous deletion at the cyclic AMP response element binding protein-binding protein (CBP) locus in a lung cancer cell line. Oncogenic roles of CBP had been suggested by functional and genetic studies; thus, involvement of CBP gene alterations in lung carcinogenesis was investigated by undertaking comprehensive analysis of genetic CBP alterations in human lung cancer.

Experimental Design: Fifty-nine cell lines and 95 surgical specimens of lung cancer were analyzed for mutations, homozygous and hemizygous deletions, and expression of the CBP gene.

Results: Homozygous CBP deletions, including two intragenic deletions, were detected in three (5.1%) lung cancer cell lines. CBP mutations, including missense, nonsense, and frame-shift mutations, were detected in six (10.2 %) cell lines and five (5.3%) surgical specimens of lung cancer. The wild-type CBP allele was retained in 9 of 11 cases with CBP mutations, and both the wild-type and mutant alleles were expressed in all the six cases with heterozygous CBP mutations examined. Three mutations with amino acid substitutions in the histone acetyltransferase domain caused significant reduction in transcription activation activity of CBP protein in vivo.

Conclusions: A fraction of lung cancers carried mutations and/or deletions of the CBP gene, suggesting that genetic CBP alterations are involved in the genesis and/or progression of a subset of lung cancers.

Key Words: Lung cancer • Tumor Suppressor Genes: Structure and Function • LOH and Marker Studies • Mapping and Cloning of Cancer Genes • Oncogenic Transcription Factors: Leukemias/Lymphomas/Solid Tumors

This article has been cited by other articles:

				A. Miremadi, M. Z. Oestergaard, P. D.P. Pharoah, and C. Caldas Cancer genetics of epigenetic genes Hum. Mol. Genet., April 15, 2007; 16(R1): R28 - R49. [Abstract] [Full Text] [PDF]

				M. V. Karamouzis, P. A. Konstantinopoulos, and A. G. Papavassiliou The Activator Protein-1 Transcription Factor in Respiratory Epithelium Carcinogenesis Mol. Cancer Res., February 1, 2007; 5(2): 109 - 120. [Abstract] [Full Text] [PDF]